Ellis Investment Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100	Closed	-$16K	–	782
2021 Q2	$16K	Hold	100	–	–	﹤0.01%	542
2021 Q1	$12K	Buy	+100	New	+$12K	﹤0.01%	556